Cambiar Investors’s Gentex GNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.05M Sell
199,755
-9,083
-4% -$215K 0.22% 68
2026
Q1
$4.56M Sell
208,838
-37,133
-15% -$861K 0.21% 66
2025
Q4
$5.72M Sell
245,971
-32,866
-12% -$792K 0.26% 63
2025
Q3
$7.89M Sell
278,837
-182,510
-40% -$4.85M 0.36% 52
2025
Q2
$10.1M Buy
461,347
+183,035
+66% +$4M 0.43% 56
2025
Q1
$6.48M Sell
278,312
-47,776
-15% -$1.22M 0.27% 86
2024
Q4
$9.37M Sell
326,088
-105,888
-25% -$3.17M 0.37% 78
2024
Q3
$12.8M Sell
431,976
-16,623
-4% -$516K 0.49% 65
2024
Q2
$15.1M Sell
448,599
-3,669
-0.8% -$127K 0.59% 48
2024
Q1
$16.3M Sell
452,268
-8,221
-2% -$284K 0.61% 47
2023
Q4
$15M Buy
460,489
+3,990
+0.9% +$123K 0.59% 52
2023
Q3
$14.9M Buy
456,499
+1,344
+0.3% +$43.1K 0.63% 50
2023
Q2
$13.3M Buy
455,155
+24,606
+6% +$678K 0.56% 48
2023
Q1
$12.1M Buy
430,549
+49,456
+13% +$1.39M 0.52% 50
2022
Q4
$10.4M Buy
381,093
+31,692
+9% +$846K 0.47% 49
2022
Q3
$8.33M Buy
349,401
+125,704
+56% +$3.45M 0.42% 58
2022
Q2
$6.26M Buy
+223,697
New +$6.51M 0.28% 84

Other funds holding GNTX

Cambiar Investors's GNTX Position: Q2 2026 in Review

Cambiar Investors reduced its Gentex (GNTX) stake by 4.3% in Q2 2026, selling an estimated $215K and leaving 199,755 shares worth $5.05M. The position accounts for 0.22% of the portfolio, ranked #68.

Cambiar Investors first reported a position in GNTX in Q2 2022 and has held it in 17 quarters since. The position peaked at $16.3M in Q1 2024. 530 funds tracked by Wall St. Rank hold GNTX as of Q2 2026.

  • Cambiar Investors held 199,755 shares of Gentex worth $5.05M as of Q2 2026.
  • Cambiar Investors sold 9,083 Gentex shares in Q2 2026, an estimated $215K.
  • Gentex made up 0.22% of Cambiar Investors's portfolio in Q2 2026, its #68 holding.
  • Cambiar Investors first reported a position in Gentex in Q2 2022 and has held it in 17 quarters since.
  • Cambiar Investors's Gentex position peaked at $16.3M in Q1 2024.
  • 530 funds tracked by Wall St. Rank held Gentex as of Q2 2026.

Based on Cambiar Investors's 13F filing for Q2 2026, filed 31 Jul 2026.